Search - tctmd.com

Displaying 81 - 100 of 615

Sort: Relevancy | Date

Event Rates, Effect Sizes Often Overestimated in Major CV Trials

News Daily News

Event Rates, Effect Sizes Often Overestimated in Major CV Trials

May 09, 2024

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

News Conference News ACC 2024

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Michael O'Riordan

April 07, 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

‘Landmark Moment’ for Middle Meningeal Artery Embolization for Subdural Hematoma

News Conference News ISC 2024

‘Landmark Moment’ for Middle Meningeal Artery Embolization for Subdural Hematoma

February 16, 2024

MOST: Eptifibatide, Argatroban Don’t Improve on IV Thrombolysis Alone

News Conference News ISC 2024

MOST: Eptifibatide, Argatroban Don’t Improve on IV Thrombolysis Alone

February 08, 2024

DAPT Works When Started Up to 3 Days After Mild Stroke, TIA

News Daily News

DAPT Works When Started Up to 3 Days After Mild Stroke, TIA

January 04, 2024

Jean-Philippe Collet, Thrombosis Expert and Trialist, Dies at 59

News Daily News

Jean-Philippe Collet, Thrombosis Expert and Trialist, Dies at 59

Yael L. Maxwell

December 18, 2023

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HCM3

News Conference News AHA 2023

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3

November 11, 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

November 11, 2023

Prophylactic Antithrombotic Therapy After TAVR

Presentation TCT 2023

Prophylactic Antithrombotic Therapy After TAVR

Presenter: Christian Hengstenberg

October 25, 2023

Case Resolution: Long-term Therapy

Presentation TCT 2023

Case Resolution: Long-term Therapy

Presenter: NULL

October 25, 2023

The Guidelines Need Updating: 3-6 Months of DAPT Is Sufficient

Presentation TCT 2023

The Guidelines Need Updating: 3-6 Months of DAPT Is Sufficient

Presenter: John Bittl

October 25, 2023

Longer Term DAPT Is What The Guidelines and Data Support

Presentation TCT 2023

Longer Term DAPT Is What The Guidelines and Data Support

Presenter: Mamas Mamas

October 25, 2023

Case Continuation: In Hospital Management

Presentation TCT 2023

Case Continuation: In Hospital Management

Presenter: Davide Cao

October 25, 2023

I Don’t Need Cangrelor With Available Potent Oral P2Y12 or 2b3a Inhibitors

Presentation TCT 2023

I Don’t Need Cangrelor With Available Potent Oral P2Y12 or 2b3a Inhibitors

Presenter: Michael Savage

October 25, 2023

Cangrelor Reduces Procedural Complications and Should Be the Default Strategy

Presentation TCT 2023

Cangrelor Reduces Procedural Complications and Should Be the Default Strategy

Presenter: Jennifer Rymer

October 25, 2023

$Unfractionated Heparin Still Works for Primary PCI!$

Presentation TCT 2023

Unfractionated Heparin Still Works for Primary PCI!

Presenter: Rod Stables

October 25, 2023

Bivalirudin Is the Most Evidence Based Antithrombin Agent for Primary PCI

Presentation TCT 2023

Bivalirudin Is the Most Evidence Based Antithrombin Agent for Primary PCI

Presenter: Gregg Stone

October 25, 2023

Case Presentation

Presentation TCT 2023

Case Presentation

Presenter: Davide Cao

October 25, 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

News Conference News TCT 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

October 24, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.